• Remed will cancel 701,519 common shares held as treasury stock, representing 2.32% of outstanding shares.
• The shares have a total book value of KRW 2 billion.
• The cancellation will reduce outstanding shares from 30,275,013 to 29,573,494.
• Paid-in capital will remain unchanged.
• The board authorized the cancellation on Oct. 19, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Remed Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261019900678), on October 19, 2026, and is solely responsible for the information contained therein.